tradingkey.logo
tradingkey.logo

Genovis Enters Into License Agreement With U.S. Biotech Company

ReutersMar 25, 2026 7:33 AM

- Genovis AB GENOb.ST:

  • ENTERS NON-EXCLUSIVE LICENSE AGREEMENT FOR ENDOS2 ENZYME TECHNOLOGY FOR ANTIBODY-DRUG CONJUGATE (ADC) DEVELOPMENT AND COMMERCIALIZATION

  • LICENSE ENABLES RESEARCH, DEVELOPMENT, MANUFACTURE, AND COMMERCIALIZATION OF ADC PRODUCTS ACROSS ALL INDICATIONS

Further company coverage: [GENOb.ST]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI